GROUP 2 PULMONARY HYPERTENSION

Clinical trials for GROUP 2 PULMONARY HYPERTENSION explained in plain language.

Never miss a new study

Get alerted when new GROUP 2 PULMONARY HYPERTENSION trials appear

Sign up with your email to follow new studies for GROUP 2 PULMONARY HYPERTENSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1 Not yet finished but already full! 1

Heart drug trial aims to help patients breathe and walk easier

Disease control Ongoing

This study is testing whether a medication called tadalafil can help people with a specific type of high blood pressure in the lungs caused by heart problems. Researchers will give the drug to 48 patients for 12 weeks and compare their results to a similar group taking a placebo.…

Matched conditions: GROUP 2 PULMONARY HYPERTENSION

Phase: NA • Sponsor: Beni-Suef University • Aim: Disease control

Last updated Mar 30, 2026 14:33 UTC

GROUP 2 PULMONARY HYPERTENSION

Get alerted when new GROUP 2 PULMONARY HYPERTENSION trials appear

Heart drug trial aims to help patients breathe and walk easier